Technology

Synlogic

$4.09
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.18 (-4.22%) Today
$0.00 (0.00%) As of 12:34 PM UTC after-hours

Why Robinhood?

You can buy or sell Synlogic and other stocks, options, and ETFs commission-free!

About SYBX

Synlogic, Inc. Common Stock, also called Synlogic, is a clinical-stage biopharmaceutical company. It engages in drug discovery and development of synthetic biotic medicines. The firm focuses on SYNB1020 and SYNB1618, which are orally administered and target hyperammonemia and phenylketonuria. It also works on SYNB1891, an intratumorally administered which treats cancer. The company was founded by Jim Collins and Tim Lu on August 28, 2017, and is headquartered in Cambridge, MA. The listed name for SYBX is Synlogic, Inc. Common Stock.

CEO
Aoife M. Brennan
Employees
76
Headquarters
Cambridge, Massachusetts
Founded
2017
Market Cap
128.12M
Price-Earnings Ratio
Dividend Yield
Average Volume
4.68M
High Today
$4.25
Low Today
$3.95
Open Price
$4.14
Volume
520.36K
52 Week High
$4.30
52 Week Low
$1.35

Collections

SYBX Earnings

-$0.49
-$0.33
-$0.16
$0.00
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
per share
Actual
Expected Mar 11, Pre-Market

You May Also Like

FUBO
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure